Crossmark

Screening for hyperuricaemia and gout: a perspective and research agenda

Crossref DOI link: https://doi.org/10.1038/nrrheum.2014.139

Published Online: 2014-08-19

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stamp, Lisa

Dalbeth, Nicola
License Information

Text and Data Mining valid from 2014-08-19
More Information

Article History

First Online: 19 August 2014

Competing interests

: L.S. declares she has received consulting fees from AstraZeneca. N.D. declares she has received consulting or speaker fees from Takeda, Savient, Menorini, AstraZeneca, Ardea, Novartis, Metabolex and Fonterra.